Celsius Holdings Faces Securities Fraud Class Action as Investors Question Core Brand Trajectory

What happened

On October 11, 2026, Rosen Law Firm announced a securities fraud class action lawsuit against Celsius Holdings, covering purchases between February 21, 2025, and June 3, 2026, with a lead plaintiff deadline of November 3, 2026. The lawsuit alleges that Celsius misled investors about the strength of its core CELSIUS brand and the success of its distribution and integration efforts during a period when the stock declined over 40% from its 2025 highs. This legal action comes on top of a first-half 2026 SG&A charge of $25.5 million, which the company already disclosed in its latest 10-Q, indicating that litigation costs are materializing. The DeepValue master report already flagged a WAIT rating with an attractive entry of $24, citing negative Celsius-brand revenue growth and margin compression, and this lawsuit adds a new downside risk to the story. Investors should treat the press release with skepticism regarding its merits, but the very existence of a class action and the associated legal expenses reinforce the view that fundamentals need to improve before the stock merits a bullish stance.

Implication

The class action lawsuit introduces unpredictable legal expenses and management distraction at a time when Celsius is trying to stabilize its core brand and improve margins. While the $25.5 million first-half 2026 legal charge was already disclosed, the total cost of litigation could rise and pressure SG&A further. The stock's current valuation (P/E 131.5, EV/EBITDA 34.9) leaves little room for error, and legal risk may cause multiple compression or delay recovery. Investors should monitor the next quarterly filings for increased legal reserves or commentary on the lawsuit, as well as any deterioration in core brand trends. Given the lawsuit's class period ends June 3, 2026, and the lead plaintiff deadline is November 3, 2026, near-term stock volatility is likely, supporting a wait-and-see approach with an attractive entry around $24.

Thesis delta

Prior thesis rated CELH a WAIT due to weak core brand fundamentals, with an attractive entry at $24. The securities fraud lawsuit adds a new risk factor that could increase legal costs and distract management, but does not alter the operational thesis. The delta is negative: the lawsuit reinforces caution, lowers confidence in a quick recovery, and strengthens the case for waiting for either a significantly lower price or clear evidence of core brand stabilization.